Forbes: Orbita driving the voice revolution in healthcare

Orbita was cited today as a leader in the race to add voice as a new vital sign, according to John Nosta of the NOSTALABS think tank, writing today in Forbes’ online edition. The power of voice, he said, “may be enough to allow voice [to] join pulse, temperature, blood pressure and respiration as a key physiology sign with vital implications.”

Ready more here.

NarrativeDx Builds Leading AI Platform for Patient Experience, Secures Series A Funding for Continued Growth

Innovative Platform Uses Natural Language Processing and Machine Learning to Help Hospitals Identify Problems, Improve Care Delivery, and Increase Referrals

AUSTIN, Texas, May 9, 2017 /PRNewswire/ -- NarrativeDx, the artificial intelligence (AI) platform for patient experience, announced Tuesday a Series A funding led by LiveOak Venture Partners, Cultivation Capital and HealthX Ventures to sustain transformational growth in their next-generation AI and natural language processing technology. As a market leader in patient experience analytics, NarrativeDx provides health care providers and organizations with the most accurate, evidence-based and automated technology solution for analyzing and understanding patient feedback.

According to a 2016 study by Accenture, excellent patient experience increases hospital revenue by 50%. NarrativeDx achieves these outcomes by partnering with healthcare organizations, patient experience and informatics leaders, and consultancies to identify key issues across departments and providers based on patient comments. These actionable insights inform human-centered solutions that improve care experiences, increase revenue, and boost referrals for a thriving healthcare system.

"We are using AI to improve healthcare experiences in a way that has never been done before," said Kyle Robertson, Founder and Chief Executive Officer, NarrativeDx. "Our partners have been eager to leverage our technology to better understand their patients' experiences. The demand we are seeing is phenomenal, and we are on track to increase our client base 10x in 2017."

The NarrativeDx AI platform analyzes comments at a per-phrase level and identifies sentiment, named doctors and nurses, key themes, procedures, and even readmission risks from complex patient comments. The technology is proven to improve patient experience measures by 80 percent, and increase outpatient referrals by over $50 million.

"NarrativeDx has built a one-of-a kind analytics engine for narrative patient experience data," said Senem Guney, PhD, Founder and Chief Experience Officer, NarrativeDx. "Our company was founded on the simple principle that patient voices matter, and by uncovering important insights from patients' own words about their experiences, we can make a meaningful improvement in the delivery of patient-centered care that brings value to the patient-consumer."

Founded in 2014 by AI engineer and IP lawyer, Kyle Robertson, JD, and Senem Guney, PhD, NarrativeDx has seen steady growth in patient experience, and the financing will further support the company as it continues to invest heavily in product innovation and improving the patient experience.

"With NarrativeDx, it's like having a data scientist on our team," said Bridget Alston, Director of Patient Experience at HackensackUMC Palisades, a NarrativeDX customer. "I have been able to shift from hours behind a desk collecting and analyzing comments to being out where I need to be with patients, staff and physicians. The NarrativeDx AI platform bridges the gap between quantitative data and qualitative data, and gives us actionable insights that we can prioritize and put into practice." 

"As a Seed Round investor, we are excited to follow-on our initial confidence in the NarrativeDx team by leading this Series A Round," said Ben Scott, General Partner of LiveOak Venture Partners. "With the best technical team in the industry, we strongly believe in their approach and are convinced that NarrativeDx has the ability to positively transform the patient experience and quickly boost hospital reputations."

"We are excited to work with NarrativeDx to see their innovative artificial intelligence technology reach its full potential," said Mark Bakken, Managing Partner of HealthX Ventures. "We see great opportunity with tools that can help hospitals manage and improve their most important relationships – those they have with their patients."

About NarrativeDx                                 
NarrativeDx, based in Austin, TX, is the artificial intelligence platform for patient experience. We help hospital leaders and care providers hear the voice of their patients. Our natural language processing and machine learning provides actionable insights from patient comments to improve their institution's patient experience, drive patient referrals, increase hospital revenue, and boost hospital reputations.

NarrativeDx's cloud-based, HIPAA-compliant, healthcare-specific AI platform uses Natural Language Processing and Machine Learning to collect, analyze, and visualizes unstructured patient feedback from internal and external sources (CAHPS Surveys, grievance letters, social review sites, etc.). Our beautiful, intuitive dashboards automatically highlight key areas for improvement (staff, doctors, units, facilities, etc.) and provide specific recommendations to improve patient experience. For additional information and a demonstration of how our technology helps our clients transform their patient experience, please visit or call +1-512-900-7720. NarrativeDx participated in Dreamit Health 2014.

About LiveOak Venture Partners
LiveOak is a $109MM Fund based in Austin, TX and was founded by Ben Scott, Krishna Srinivasan, and Venu Shamapant (all formerly of Austin Ventures).  While many of LiveOak's investments begin in the early stages, LiveOak is a full lifecycle investor focused on technology and technology-driven service companies based in Texas. 

With over 16 years of successful early stage investing in Texas, the Founders of LiveOak have helped entrepreneurs create industry-leading companies, such as Spatial Wireless (acquired by Alcatel-Lucent), Navini Networks (acquired by Cisco Systems), LifeSize Technologies (acquired by Logitech), Mavenir Systems, and StackEngine (Acquired by Oracle).
Follow: @liveoakvp

About Cultivation Capital
Cultivation Capital is a venture capital firm supporting extraordinary entrepreneurs. We are a family of venture funds investing in technology, life sciences, and financial technology companies. These funds have backed over 38 companies since the firm's founding in 2012, making us one of the most active seed investors in the country. Cultivation Capital helps businesses achieve pivotal milestones with the help of our general partners, investors, and other portfolio companies. For more information, please visit

About HealthX Ventures
HealthX Ventures is a digital healthcare-focused venture capital fund that supports early/seed stage, high-growth companies in all areas of digital health, including companies who are making healthcare safer, more efficient and more affordable. The firm is investing out of its flagship fund and is led by experienced entrepreneurs, investors, and industry experts who have grown companies and led change across the healthcare system. Learn more at

Contact: Ashley Conway
Director of Marketing 

Madison’s Emergence as Healthtech Hub on Display at HIMSS

Greater Madison companies to be well-represented at annual health IT conference in Orlando

MADISON, WI – Befitting its status as an emerging hub for health innovation, Greater Madison companies will be well-represented at the 2017 HIMSS Annual Conference & Exhibition taking place Feb. 19-23 in Orlando. The annual conference, which brings together more than 40,000 health IT professionals, clinicians, executives and vendors from around the world, will feature exhibits and pavilions from a diverse offering of health innovation companies located in Madison.

Redox Raises $9M Led by RRE Ventures to Scale Interoperable Network of Health Systems and Applications

Redox, the leading integration platform for digital healthcare applications, announced today that it has closed a $9 million Series B financing. RRE Ventures led the round with participation from existing investors .406 VenturesHealthX Ventures, and Flybridge Capital Partners. Redox will use the new capital to accelerate its product roadmap along the way to building the industry standard platform for seamless interoperability between health technology developers and health systems.